Conjunctival pyogenic granuloma associated with intravitreal bevacizumab injection.
OBJECTIVE
To report a case of conjunctival pyogenic granuloma after intravitreal injection of anti-vascular endothelial growth factor, bevacizumab.


METHODS
A 52-year-old patient after 3 intravitreal bevacizumab injections was found to have a vascular conjunctival nodule at the injection site. A pathologic analysis of the vascular conjunctival nodule was performed after surgical excision.


RESULTS
The pathologic analysis revealed a conjunctival pyogenic granuloma.


CONCLUSIONS
Conjunctival pyogenic granuloma can complicate an otherwise uneventful intravitreal anti-vascular endothelial growth factor injection.
The Goldschleger Eye Institute, Sheba Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel Hashomer, Israel.
Oded
O
Sagiv
Ilia
I
Piven
Mordechai
M
Rosner